Cargando…
Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer
Sirtuin-3 (SIRT3), a major mitochondria NAD+-dependent deacetylase, may target mitochondrial proteins for lysine deacetylation and also regulate cellular functions. And, SIRT3 is an emerging instrumental regulator of the mitochondrial adaptive response to stress, such as metabolic reprogramming and...
Autores principales: | Chen, Y, Fu, L L, Wen, X, Wang, X Y, Liu, J, Cheng, Y, Huang, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944233/ https://www.ncbi.nlm.nih.gov/pubmed/24503539 http://dx.doi.org/10.1038/cddis.2014.14 |
Ejemplares similares
-
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
por: Huang, Guoyu, et al.
Publicado: (2018) -
Sirtuin-3 (SIRT3), a Novel Potential Therapeutic Target for Oral Cancer
por: Alhazzazi, Turki Y, et al.
Publicado: (2011) -
Survival or death: disequilibrating the oncogenic and tumor suppressive autophagy in cancer
por: Liu, B, et al.
Publicado: (2013) -
SIRT3: Oncogene and Tumor Suppressor in Cancer
por: Torrens-Mas, Margalida, et al.
Publicado: (2017) -
Sirtuins (SIRTs) As a Novel Target in Gastric Cancer
por: Poniewierska-Baran, Agata, et al.
Publicado: (2022)